Search stocks

Find any stock by ticker or company name

Home

RLAY

Relay Therapeutics, Inc. (RLAY)

NGM – Real Time Price. Currency in USD

20.01

+0.03 (0.13%)

Market open: Aug 12, 2026, 11:24 AM EDT

20.17

+0.18 (0.90%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Instagram
Telegram
LinkedIn

Home
Watchlist
Markets
Calendar
Screener
News
About

RLAY - Relay Therapeutics, Inc. Latest News | Finranks

Home

RLAY

Relay Therapeutics, Inc. (RLAY)

NGM – Real Time Price. Currency in USD

20.01

+0.03 (0.13%)

Market open: Aug 12, 2026, 11:24 AM EDT

20.17

+0.18 (0.90%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

07.08.2026

Relay Therapeutics, Inc. (RLAY) Reports Q2 Loss, Lags Revenue Estimates

Relay Therapeutics, Inc. (RLAY) came out with a quarterly loss of $0.41 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.41 per share a year ago.

06.08.2026

Relay Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Updates

Selected z ovegalisib plus atirmociclib as go-forward triplet regimen for 1L breast cancer; Phase 3 1L trial in endocrine - sensitive patients expected to initiate in early 2027, subject to regulatory feedback

Videos

No Data

There is no data to display

Press releases

06.08.2026

Search stocks

Relay Therapeutics, Inc. (RLAY)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Relay Therapeutics, Inc. (RLAY)

Relay Therapeutics, Inc. (RLAY) Reports Q2 Loss, Lags Revenue Estimates

Relay Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Updates

Videos

No Data

Press releases

Relay Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Updates